KMT2A and leukemia: MSP, RT–PCR and Western blot were performed to respectively analyse the methylation status of HOXA10 promoter CpG island, mRNA expression of MLL1 and HOXA10, protein expression and H3K4 methylation status in the leukaemia cell line (HL-60) with and without MLL1 knockdown (Figure 7).